Forest Labs, Janssen Sue Several Drug Makers Over Bystolic

Date : 03/14/2012 @ 2:02PM
Source : Dow Jones News
Stock : Forest Laboratories Inc. (FRX)
Quote : 99.0  0.0 (0.00%) @ 2:05AM

Forest Labs, Janssen Sue Several Drug Makers Over Bystolic

   DOW JONES NEWSWIRES 
 

Forest Laboratories Inc. (FRX) and Johnson & Johnson's (JNJ) Janssen Pharmaceutica NV sued several drug makers over plans to market generic versions of Forest's Bystolic hypertension drug, citing an existing patent.

The lawsuit before the U.S. District Court in Delaware names units of Amerigen Pharmaceuticals Inc., Glenmark Pharmaceuticals Ltd. (532296.BY), Hetero USA Inc., Torrent Pharmaceuticals Ltd. (500420.BY) and Watson Pharmaceuticals Inc. (WPI) as defendants. The two drug makers also sued Alkem Laboratories Ltd. and Indchemie Health Specialties Pvt. Ltd in Chicago's U.S. district court.

Forest's patent on the blood-pressure medication expires in December 2021 after patent-term extension.

Shares of Forest were up 10 cents at $33.80 mid-Wednesday, in line with the broader market. Johnson & Johnson was off 21 cents at $65.12.

-By Drew FitzGerald, Dow Jones Newswires; 212-416-2909; Andrew.FitzGerald@dowjones.com



Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.